Literature DB >> 8371339

Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene.

J G Keck1, G R Kovacs, B Moss.   

Abstract

The A1L, A2L, and G8R open reading frames (ORFs) were previously shown by transfection assays to encode transactivators of late gene expression. We now present evidence that the 17-kDa protein product of the A1L gene can function in vitro as a transcription factor. Simultaneous overexpression of the transactivators was achieved by coinfecting HeLa cells with one recombinant vaccinia virus that encodes the bacteriophage T7 RNA polymerase and three recombinant vaccinia viruses that contain copies of A1L, A2L, and G8R ORFs regulated by T7 promoters. Extracts from the recombinant virus-infected cells exhibited greatly enhanced late in vitro transcription activity and served as a source of factors. The 17-kDa product of the A1L ORF represented approximately 8% of the ammonium sulfate-precipitated cell protein and copurified with a late transcription factor activity. The transcription factor activity could be specifically immunodepleted with immobilized antibody to the bacterially expressed A1L-encoded protein, providing additional evidence for its identity and role. A sequence encoding six consecutive histidines was added to the A1L ORF, which was then incorporated into the genome of a baculovirus expression vector. The 17-kDa protein, synthesized in insect cells and purified by binding to an Ni(2+)-chelating affinity column, could replace the vaccinia virus-overexpressed 17-kDa protein in transcription assays. In addition to the 17-kDa product of the A1L gene, which was named vaccinia virus late transcription factor 2, the proteins that stimulate specific transcription of late promoter-regulated templates included the viral multisubunit RNA polymerase, vaccinia virus late transcription factor 1 (the product of the G8R ORF), and at least one other partially purified protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371339      PMCID: PMC237991     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Identification of a temperature-sensitive mutant of vaccinia virus defective in late but not intermediate gene expression.

Authors:  M S Carpenter; A M DeLange
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.

Authors:  C J Baldick; J G Keck; B Moss
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation.

Authors:  N Harris; R Rosales; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  Mutational analysis of a predicted zinc-binding motif in the 26-kilodalton protein encoded by the vaccinia virus A2L gene: correlation of zinc binding with late transcriptional transactivation activity.

Authors:  J G Keck; F Feigenbaum; B Moss
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.

Authors:  C J Baldick; B Moss
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  RNA polymerase-associated transcription specificity factor encoded by vaccinia virus.

Authors:  B Y Ahn; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.

Authors:  Y Zhang; J G Keck; B Moss
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Promoter DNA contacts made by the vaccinia virus early transcription factor.

Authors:  S S Broyles; J Li; B Moss
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

10.  Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus.

Authors:  R Janknecht; G de Martynoff; J Lou; R A Hipskind; A Nordheim; H G Stunnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more
  17 in total

1.  Common origin of four diverse families of large eukaryotic DNA viruses.

Authors:  L M Iyer; L Aravind; E V Koonin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene.

Authors:  A L Passarelli; G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  A vaccinia virus late transcription factor copurifies with a factor that binds to a viral late promoter and is complemented by extracts from uninfected HeLa cells.

Authors:  C F Wright; A E Hubbs; S K Gunasinghe; B W Oswald
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  A cellular protein binds vaccinia virus late promoters and activates transcription in vitro.

Authors:  M Zhu; T Moore; S S Broyles
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions.

Authors:  X Hu; L J Carroll; E J Wolffe; B Moss
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  The vaccinia virus A18R protein plays a role in viral transcription during both the early and the late phases of infection.

Authors:  D A Simpson; R C Condit
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  The A2L intermediate gene product is required for in vitro transcription from a vaccinia virus late promoter.

Authors:  A E Hubbs; C F Wright
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.

Authors:  R Rosales; G Sutter; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Authors:  Karin M Sperling; Astrid Schwantes; Caroline Staib; Barbara S Schnierle; Gerd Sutter
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.